Cargando…

Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER‐Medicare analysis

BACKGROUND: The relationship between metastatic colorectal cancer (mCRC) and venous thromboembolism (VTE) is poorly defined in the modern era. Our objective was to examine impact of putative risk factors including newer treatments and anti‐angiogenic therapy on VTE incidence and survival in a modern...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ades, Steven, Pulluri, Bhargavi, Holmes, Chris E., Lal, Inder, Kumar, Santosh, Littenberg, Benjamin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041082/ https://www.ncbi.nlm.nih.gov/pubmed/35129311 http://dx.doi.org/10.1002/cam4.4581

Ejemplares similares

Overview of the SEER—Medicare Health Outcomes Survey Linked Dataset
por: Ambs, Anita, et al.
Publicado: (2008)

Associations between initiating antihypertensive regimens on stage I–III colorectal cancer outcomes: A Medicare SEER cohort analysis
por: Balkrishnan, Rajesh, et al.
Publicado: (2021)

Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER‐Medicare analysis
por: Sadetsky, Natalia, et al.
Publicado: (2020)

Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation
por: Beebe‐Dimmer, Jennifer L., et al.
Publicado: (2019)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER‐medicare analysis
por: Ailawadhi, Sikander, et al.
Publicado: (2017)

Real‐world experience of carfilzomib‐associated cardiovascular adverse events: SEER‐Medicare data set analysis
por: Bishnoi, Rohit, et al.
Publicado: (2020)

Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data
por: Connelly-Frost, Alexandra, et al.
Publicado: (2013)

Older soft tissue sarcoma patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data
por: Shantakumar, Sumitra, et al.
Publicado: (2015)

Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival
por: Ramos, Jorge D., et al.
Publicado: (2016)

Opportunities for Personalizing Colorectal Cancer Care: An Analysis of SEER-Medicare Data
por: Rivers, Zachary T., et al.
Publicado: (2022)

Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER‐Medicare‐linked data resource
por: Lam, Clara, et al.
Publicado: (2018)

Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-medicare data from 1993 to 2005
por: Yasmeen, Shagufta, et al.
Publicado: (2013)

Chemotherapy treatments, costs of care, and survival for patients diagnosed with small cell lung cancer: A SEER‐Medicare study
por: Shao, Changxia, et al.
Publicado: (2019)

Venous thromboembolism and subsequent risk of cancer in patients with liver disease: a population-based cohort study
por: Montomoli, Jonathan, et al.
Publicado: (2015)

Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data
por: Goto, Daisuke, et al.
Publicado: (2019)

Comparison of SEER Treatment Data With Medicare Claims
por: Noone, Anne-Michelle, et al.
Publicado: (2016)

Expression of Tissue Factor in Epithelial Ovarian Carcinoma Is Involved in the Development of Venous Thromboembolism
por: Sakurai, Manabu, et al.
Publicado: (2017)

Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review
por: Xiong, Wei, et al.
Publicado: (2023)

Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic
por: Holmes, Chris E., et al.
Publicado: (2020)

Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER–Medicare Analysis
por: Liang, Peter S., et al.
Publicado: (2020)

Geographic and intra‐racial disparities in early‐onset colorectal cancer in the SEER 18 registries of the United States
por: Abualkhair, Wesal H., et al.
Publicado: (2020)

Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism
por: Ullah, Fauzia, et al.
Publicado: (2023)

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020)

Screening for cancer in unprovoked venous thromboembolism
por: Shivji, Salma, et al.
Publicado: (2019)

Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
por: Park, Haesuk, et al.
Publicado: (2022)

Venous thromboembolism among Medicare acute ischaemic stroke patients with and without COVID-19
por: Tong, Xin, et al.
Publicado: (2022)

SEER-MHOS: A New Federal Collaboration on Cancer Outcomes Research
por: Clauser, Steven B., et al.
Publicado: (2008)

Venous Thromboembolic Complications in Colorectal Surgery
por: Huh, Jung Wook
Publicado: (2015)

Impact of serious mental illness on the treatment and mortality of older patients with locoregional high‐grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER‐Medicare patients diagnosed between 2006 and 2013
por: Fried, Dennis A., et al.
Publicado: (2019)

Do Not Ignore Those Raccoon Eyes; They May Indicate Lethal AL Amyloidosis
por: Sapkota, Surendra, et al.
Publicado: (2022)

Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study
por: Kenmotsu, Hirotsugu, et al.
Publicado: (2021)

Venous thromboembolism and radiation therapy: The final radiation‐induced thrombosis study analysis
por: Daguenet, Elisabeth, et al.
Publicado: (2022)

Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2022)

Incidence, risk factors, and outcomes of central venous catheter‐related thromboembolism in breast cancer patients: the CAVECCAS study
por: Debourdeau, Philippe, et al.
Publicado: (2017)

Application of risk factors for venous thromboembolism in patients with multiple myeloma starting chemotherapy, a real‐world evaluation
por: Baker, Hailey A., et al.
Publicado: (2018)

A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
por: Chen, Ying, et al.
Publicado: (2021)

Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea
por: Shin, Wonkyo, et al.
Publicado: (2021)

A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center
por: Vu, Khanh, et al.
Publicado: (2015)

Venous and Arterial Thromboembolism in Patients with Metastatic Lung Cancer
por: Qin, Ya, et al.
Publicado: (2023)

Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study
por: Icht, Oded, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_umqrcitj3t65jth6s536h88shh